UNLOCKD Inc., a publicly traded holding company focused on building a diversified consumer health and wellness platform, has signed a binding Letter of Intent to acquire 100% of Ancient Extracts Ltd, operating as Ancient Extracts UK. The proposed transaction, announced through NEWMEDIAWIRE, would bring the British direct-to-consumer functional wellness business into UNLOCKD's portfolio and add approximately $920,000 in annualized revenue based on preliminary management-provided financial information.
The significance of the announcement lies in its potential to accelerate UNLOCKD's revenue growth and geographic reach. Ancient Extracts UK currently reports about $77,000 in monthly revenue, and management indicates the business is approaching the $1 million annualized revenue milestone. By combining Ancient Extracts UK with UNLOCKD's existing Ancient Extracts USA business, the company would establish a presence in both the United States and United Kingdom, creating a transatlantic platform for functional wellness products that include mushroom-based offerings, specialty coffee formulations, Himalayan shilajit, and ceremonial matcha.
Under the binding LOI dated October 26, 2026, UNLOCKD proposes to acquire Ancient Extracts UK for $1.8 million in restricted BFCH common stock, with additional founder management equity, performance-based incentives, financing-linked cash consideration, and continuing employment arrangements contemplated under the agreement. The structure is designed to align the transaction with execution, according to John P. Gorst, Chief Executive Officer of UNLOCKD. "The proposed acquisition provides for BFCH to acquire 100% of Ancient Extracts UK primarily through restricted common stock, with additional consideration tied to management participation, performance, and financing," Gorst said. "Just as importantly, closing is conditioned upon qualifying capital, completion of an acceptable financial audit, satisfactory due diligence, and definitive agreements."
The deal is not without conditions. Closing requires BFCH to raise at least $500,000 in qualifying financing, completion of an acceptable financial audit of Ancient Extracts UK, satisfactory due diligence, required approvals, and execution of definitive agreements. The LOI includes a 120-day exclusivity period. These conditions introduce execution risk, but they also provide a framework that management believes safeguards the interests of BFCH and its shareholders.
For investors, the announcement signals UNLOCKD's intent to scale its consumer wellness platform through strategic acquisitions. The company's portfolio already includes Ancient Extracts USA, EVERMIND, and 1ENERGY, and the addition of Ancient Extracts UK would expand its direct-to-consumer e-commerce capabilities and recurring subscription customer base. More details on Ancient Extracts UK's operating economics, gross margins, customer retention, subscription revenue, and digital marketing performance are expected in a subsequent announcement. Additional information about UNLOCKD is available at https://unlockdinc.com/, while Ancient Extracts UK's product offerings can be viewed at https://www.ancientextracts.co.uk/.
The proposed acquisition remains subject to its closing conditions, and there can be no assurance that the transaction will be completed. Financial information concerning Ancient Extracts UK is preliminary, management-provided, and unaudited, and annualized revenue figures are extrapolated from reported monthly results. Nonetheless, the LOI represents a concrete step toward UNLOCKD's stated goal of building a larger wellness business, with management intending to outline a vision for growing Ancient Extracts into a business capable of generating $100 million or more in annual revenue.
